angiotensin IV is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-07-05. Where a claim depends on a specific study, the study is described rather than over-claimed.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
Dihexa is commonly handled as a lyophilized powder in laboratory settings. Storage at -20 °C in a desiccated, light-protected container is typical for peptides. Repeated freeze-thaw cycles can degrade the material, so aliquoting is often recommended. Aqueous solutions may be less stable than organic stocks and should be prepared fresh when possible. Personnel should follow institutional safety procedures and avoid uncontrolled exposure. Because human effects are not well characterized, handling precautions are prudent.
The proposed mechanism of dihexa centers on activation of the hepatocyte growth factor receptor, also called c-Met. Some studies suggest it acts as a mimetic of hepatocyte growth factor, promoting signaling pathways involved in synapse formation. Other work has explored interactions with angiotensin IV pathways, but the exact binding targets remain uncertain. Laboratory findings come mainly from cell cultures and animal models. Whether these mechanisms operate similarly in humans is an open question. Researchers have not established a single, universally accepted mechanism of action.
| Property | Value | Notes |
|---|---|---|
| Common name | Dihexa | Shorthand used in research literature and supplier catalogs. |
| CAS Registry Number | 1401708-83-5 | Identifier assigned to the synthetic peptide. |
| Molecular formula | C27H44N4O5 | Reported formula; verify with a certificate of analysis. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Typical storage | −20 °C or below, desiccated | Common condition for peptide stability. |
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
Cherry juice is a fruit juice consisting of the juice of cherries. It is consumed as a beverage and used as an ingredient in various foods, processed foods and beverages. It is also marketed as a health supplement. It is produced by hot- or cold-pressing cherries, collecting the juice, and then filtering and pasteurizing it.
In his classic description of diabetes, Aretaeus of Cappadocia (fl. early 2nd century AD) noted the excessive amount of urine that passed through the kidney. He also noted its rarity ("Diabetes is a wonderful affection, not very frequent among men..."). He described the disease as "a melting down of the flesh and limbs into urine" and attributed it to the bladder and kidneys, commenting that "life (with diabetes) is short, disgusting and painful." Aretaeus's contemporary Galen (129–200 AD) stressed that diabetes was a disease of the kidneys and affirmed its rarity, having observed it "only twice" at the time he wrote On the affected parts. Aretaeus and the others authors under discussion did not differentiate between diabetes mellitus and diabetes insipidus. It is assumed that they were referring to diabetes mellitus, although Swedish physician F. Henschen has suggested that Aretaeus and Galen may have instead been referring to diabetes insipidus. For all practical purposes, however, diabetes insipidus remained unrecognized well into the 17th century.
==== Pregnancy ==== During pregnancy, DHEA-S is metabolized into the sulfates of 16α-hydroxy-DHEA and 15α-hydroxy-DHEA in the fetal liver as intermediates in the production of the estrogens estriol and estetrol, respectively.
===== Efficacy ===== Cyproterone acetate has been proven effective in restraining sexual drive and fantasies in patients with high libido. Its usage in treating hypersexuality has been advocated by the World Federation of Societies of Biological Psychiatry (WFSBP).
=== Greenlandic === The longest word in Greenlandic is Nalunaarasuartaateeraaranngualioqatigiiffissualioriataallaqqissupilorujussuanngortartuinnakasinngortinniamisaalinnguatsiaraluallaqqooqigaminngamiaasiinngooq, which has 156 letters. The rough translation of this word is: "There were reports that they apparently – God knows for how many times – once again had considered whatever I, my poor condition despite, still could be considered to be quite adept and resourceful as initiator to put a consortium together for the establishment of a range of tiny radio stations." The word is a tongue twister that forms an entire sentence, rather than being a word or phrase commonly heard in Greenland. Inuussutissarsiorsinnaajunnaarnersiutilik, consisting of 41 letters, is the longest singular word in the Greenlandic dictionary.
Sources: en.wikipedia.org
=== Automobile airbags and aircraft evacuation slides === Airbag formulations through late 1990s to early 2000s contained mixtures of oxidizers, sodium azide and other agents including ignitors and accelerants. An electronic controller detonates this mixture during an automobile crash:
To overcome the limit, a small part of the system is treated quantum-mechanically (typically active-site of an enzyme) and the remaining system is treated classically. In more sophisticated implementations, QM/MM methods exist to treat both light nuclei susceptible to quantum effects (such as hydrogens) and electronic states. This allows generating hydrogen wave-functions (similar to electronic wave-functions). This methodology has been useful in investigating phenomena such as hydrogen tunneling. One example where QM/MM methods have provided new discoveries is the calculation of hydride transfer in the enzyme liver alcohol dehydrogenase. In this case, quantum tunneling is important for the hydrogen, as it determines the reaction rate.
== Further reading == Aikin, Jane (2010). "Histories of the Library of Congress". Libraries & the Cultural Record. 45 (1): 5–24. doi:10.1353/lac.0.0113. S2CID 161865550. Anderson, Gillian B. (1989), "Putting the Experience of the World at the Nation's Command: Music at the Library of Congress, 1800–1917", Journal of the American Musicological Society, 42 (1): 108–49, doi:10.2307/831419, JSTOR 831419 Bisbort, Alan, and Linda Barrett Osborne. The Nation's Library: The Library of Congress, Washington, D. C. (Library of Congress, 2000) Cole, John Young. Jefferson's legacy: a brief history of the Library of Congress (Library of Congress, 1993) Cole, John Young. "The library of congress becomes a world library, 1815–2005." Libraries & culture (2005) 40#3: 385–398. in Project MUSE Cope, R. L. "Management Review of the Library of Congress: The 1996 Booz Allen & Hamilton Report," Australian Academic & Research Libraries (1997) 28#1 online Mearns, David Chambers. The Story Up to Now: The Library of Congress, 1800–1946 (1947), detailed narrative Ostrowski, Carl. Books, Maps, and Politics: A Cultural History of the Library of Congress, 1783–1861 (2004) Rosenberg, Jane Aiken. The Nation's Great Library: Herbert Putnam and the Library of Congress, 1899–1939 (University of Illinois Press, 1993) Shevlin, Eleanor F.; Lindquist, Eric N. (2010). "The Center for the Book and the History of the Book". Libraries & the Cultural Record. 45 (1): 56–69. doi:10.1353/lac.0.0112. S2CID 161311744. Tabb, Winston; et al. (2003). "Library of Congress". Encyclopedia of Library and Information Science.
If an anaphylactoid reaction occurs the acetylcysteine is temporarily halted or slowed and antihistamines and other supportive care is administered. For example, a nebulised beta-agonist like salbutamol may be indicated in the event of significant bronchospasm (or prophylactically in patients with a history of bronchospasm secondary to acetylcysteine). It is also important to closely monitor fluids and electrolytes.
== Contraindications == Nothing is known about the use of alfatradiol during pregnancy or lactation, or in patients under 18 years of age. The package leaflet recommends against using it under these circumstances.
Sources: en.wikipedia.org
=== First attempts, halting follow-up === When jamming was first attempted by the Germans it was in a much more clever fashion than had been anticipated. The observation that the transmissions of the individual stations were spread out in time, in order to avoid mutual interference, was exploited. A system was designed to send back spurious broadband pulses on a chosen CH station's time slot. The CH operator could avoid this signal simply by changing their time slot slightly, so the jamming was not received. This caused the station's signals to start overlapping another's time slot, so that station would attempt the same cure, affecting another station in the network, and so forth. A series of such jammers were set up in France starting in July 1940, and soon concentrated into a single station in Calais that affected CH for some time. However, the timing of these attempts was extremely ill-considered. The British quickly developed operational methods to counteract this jamming, and these had effectively eliminated the effect of the jamming by the opening of the Battle of Britain on 10 July. The Germans were well on their way to develop more sophisticated jamming systems, but these were not ready for operation until September. This meant that the CH system was able to operate unmolested throughout the Battle, and led to its well-publicized successes. By the opening of the Battle in July the German Luftwaffe operational units were well aware of CH, and had been informed by the DVL that they could not expect to remain undetected, even in clouds.
Annual award dinner for someone who promoted the ideals of Zionism and Americanism - honorees have included Gerald Ford, Robert F. Kennedy, Hugh Scott, and Frank Church. Through its American Israel Friendship League it distributed books and periodicals to over 2,000 university libraries, sponsored seminars, and discussion groups. Absorbed B'rith Abraham in 1981. Free Sons of Israel - Originally Independent Order of Free Sons of Israel. The first lodge was established on January 10, 1849, in New York at the corner of Ridge and Houston Street. It was named Noah #1 after Mordecai Noah. A Constitutional Grand Lodge was convened on March 10 and 22 outlining the rules for order, regalia, and the process for creating subordinate lodges. Abraham Lodge #2 was instituted on May 7, 1849, and later that year Reuben Lodge #3 was joined by 30 former members of Struve Lodge #17 of the German Order of the Harugari. On April 15, 1865, the Order took part in the New York funeral ceremonies for Abraham Lincoln. Throughout the nineteenth century membership was restricted to Jewish men, but unofficial female auxiliaries did spring up. By the late 1970s women were accepted as regular members. The order had 453 members in 7 lodges in 1856, and 928 in 10 lodges in 1863, all within the state of New York. The first lodge outside of New York was Benjamin #15 in Philadelphia, on July 30, 1865. In 1899 the Order had 15,000 members in 104 lodges spread across 21 states. In 1923 the order had 6,645 members in 78 lodges.
Chromosome studies are used in the general genetics clinic to determine a cause for developmental delay or intellectual disability, birth defects, dysmorphic features, or autism. Chromosome analysis is also performed in the prenatal setting to determine whether a fetus is affected with aneuploidy or other chromosome rearrangements. Finally, chromosome abnormalities are often detected in cancer samples. A large number of different methods have been developed for chromosome analysis:
=== Ambient ionization mass spectrometry for disease diagnosis === The MasSpec Pen technology is based on the principles of ambient ionization, in which ions are generated directly from a sample without need for extensive sample preparation or chromatographic separations. The MasSpec Pen can further be categorized as a solid-liquid extraction based ambient ionization method, described as methods that utilize a solvent system to gently extract molecules from a sample surface that are subsequently analyzed by a mass spectrometer. Desorption electrospray ionization (DESI) was the first liquid-based ambient ionization MS method. DESI employed a spray of charged solvent droplets to bombard a sample surface to desorb and ionize molecules from the sample surface, which are then directed towards and analyzed by a mass spectrometer. DESI-MS and other solvent-based ambient ionization MS methods has been widely employed for the analysis of small molecules, primarily metabolites and lipids, directly from biological tissue specimens to determine their molecular composition and leverage the mass spectral data acquired for diagnostic purposes. These methods have been deployed for the discrimination of normal and cancerous regions of tissue samples for many solid tumor indications, including breast, brain, prostate, ovarian, and colorectal, among others. Multivariate statistical analysis methods are often utilized to generate statistical models from the mass spectral data acquired from direct analysis of tissue samples to distinguish between healthy and diseased tissues.
The distribution of medications has special drug safety and security considerations. Some drugs require cold chain management in their distribution. The industry uses track and trace technology, though the timings for implementation and the information required vary across different countries, with varying laws and standards.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.
It is produced by chemical synthesis, not extracted from plants or animals. Its design is based on a naturally occurring peptide fragment. Suppliers sell it as a research chemical.
No, dihexa is a modified analog of angiotensin IV. The two share a structural relationship but differ in chemical details. Research on one does not automatically apply to the other.
Liquid chromatography–mass spectrometry is commonly used. It provides molecular mass and purity information. Other methods may include HPLC with ultraviolet detection.